{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:10:57Z","timestamp":1773277857620,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":4266,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.ymthe.2004.10.018","type":"journal-article","created":{"date-parts":[[2004,12,14]],"date-time":"2004-12-14T15:22:01Z","timestamp":1103037721000},"page":"237-244","source":"Crossref","is-referenced-by-count":25,"title":["Passive Immunotherapy for Anthrax Toxin Mediated by an Adenovirus Expressing an Anti-Protective Antigen Single-Chain Antibody"],"prefix":"10.1016","volume":"11","author":[{"given":"Kazuhiko","family":"Kasuya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie L.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Olivier","family":"Alipui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil R.","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald G.","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2004.10.018_bib1","series-title":"Vaccines","first-page":"629","article-title":"Anthrax","author":"Brachman","year":"1999"},{"key":"10.1016\/j.ymthe.2004.10.018_bib2","first-page":"335","article-title":"Anthrax: clinical features, pathogenesis, and potential biological warfare threat","volume":"20","author":"Friedlander","year":"2000","journal-title":"Curr. Clin. Top. Infect. Dis."},{"key":"10.1016\/j.ymthe.2004.10.018_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1286-4579(99)80004-5","article-title":"Molecular pathogenesis of Bacillus anthracis infection","volume":"1","author":"Little","year":"1999","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ymthe.2004.10.018_bib4","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax as a biological weapon, 2002: updated recommendations for management","volume":"87","author":"Inglesby","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2004.10.018_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2958.1999.01137.x","article-title":"Germination of Bacillus anthracis spores within alveolar macrophages","volume":"31","author":"Guidi-Rontani","year":"1999","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ymthe.2004.10.018_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1369-5274(00)00168-5","article-title":"Bacillus anthracis, a bug with attitude!","volume":"4","author":"Baillie","year":"2001","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ymthe.2004.10.018_bib7","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"Dixon","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2004.10.018_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0966-842X(99)01507-3","article-title":"Understanding Bacillus anthracis pathogenesis","volume":"7","author":"Hanna","year":"1999","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ymthe.2004.10.018_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/IAI.39.1.371-376.1983","article-title":"Evidence for plasmid-mediated toxin production in Bacillus anthracis","volume":"39","author":"Mikesell","year":"1983","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2004.10.018_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1172\/JCI0216204","article-title":"Development of an improved vaccine for anthrax","volume":"110","author":"Leppla","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2004.10.018_bib11","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2004.10.018_bib12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/JB.85.1.230-236.1963","article-title":"Studies on immunity in anthrax","author":"Puziss","year":"1963","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ymthe.2004.10.018_bib13","series-title":"The Anthrax Vaccine: Is It Safe? Does It Work? Committee to Assess the Safety and Efficacy of the Anthrax Vaccine","author":"Jollenbeck","year":"2003"},{"key":"10.1016\/j.ymthe.2004.10.018_bib14","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume":"16","author":"Ivins","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2004.10.018_bib15","article-title":"DNA-based vaccination against anthrax protects against aerosol challenges","author":"Galloway","year":"2003"},{"key":"10.1016\/j.ymthe.2004.10.018_bib16","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1089\/104303403322542310","article-title":"Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen","volume":"14","author":"Tan","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.10.018_bib17","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3201\/eid0808.010516","article-title":"Passive antibody administration (immediate immunity) as a specific defense against biological weapons","volume":"8","author":"Casadevall","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ymthe.2004.10.018_bib18","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/IAI.56.7.1807-1813.1988","article-title":"Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin","volume":"56","author":"Little","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2004.10.018_bib19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1099\/13500872-142-3-707","article-title":"Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies","volume":"142","author":"Little","year":"1996","journal-title":"Microbiology"},{"key":"10.1016\/j.ymthe.2004.10.018_bib20","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt0602-597","article-title":"Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity","volume":"20","author":"Maynard","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2004.10.018_bib21","first-page":"124","article-title":"Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector","volume":"2","author":"Hersh","year":"1995","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2004.10.018_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0092-8674(92)90213-V","article-title":"In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium","volume":"68","author":"Rosenfeld","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2004.10.018_bib23","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/JVI.70.11.7498-7509.1996","article-title":"Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy","volume":"70","author":"Mittereder","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.10.018_bib24","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1128\/JCM.29.7.1439-1446.1991","article-title":"Comparisons of standard curve-fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay","volume":"29","author":"Plikaytis","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ymthe.2004.10.018_bib25","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.69.7.4509-4515.2001","article-title":"Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein","volume":"69","author":"Price","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2004.10.018_bib26","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/S0021-9258(17)38364-3","article-title":"Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process","volume":"261","author":"Friedlander","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2004.10.018_bib27","series-title":"Molecular Cloning: A Laboratory Manual","year":"1989"},{"key":"10.1016\/j.ymthe.2004.10.018_bib28","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/CMR.13.4.602-614.2000","article-title":"Passive immunity in prevention and treatment of infectious diseases","volume":"13","author":"Keller","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ymthe.2004.10.018_bib29","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1016\/S0264-410X(01)00197-9","article-title":"Passive transfer of protection against Bacillus anthracis infection in a murine model","volume":"19","author":"Beedham","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2004.10.018_bib30","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1128\/IAI.70.2.544-550.2002","article-title":"Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization","volume":"70","author":"Kobiler","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2004.10.018_bib31","first-page":"759","article-title":"Successful treatment of rhesus monkeys for septicemia anthrax","volume":"10","author":"Lincoln","year":"1964","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ymthe.2004.10.018_bib32","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/IAI.65.12.5171-5175.1997","article-title":"Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs","volume":"65","author":"Little","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2004.10.018_bib33","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2004.10.018_bib34","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nbt891","article-title":"Human antibodies from immunized donors are protective against anthrax toxin in vivo","volume":"21","author":"Wild","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2004.10.018_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-8518-2-5","article-title":"Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed","volume":"2","author":"Sawada-Hirai","year":"2004","journal-title":"J. Immune Based Ther. Vaccines"},{"key":"10.1016\/j.ymthe.2004.10.018_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1126\/science.1074590","article-title":"Microbiology: a binding contract for anthrax","volume":"297","author":"Bull","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2004.10.018_bib37","article-title":"Protection against inhalation anthrax-induced lethality by a human monoclonal antibody to protective cynomolgus monkeys","author":"Beebe","year":"2003"},{"key":"10.1016\/j.ymthe.2004.10.018_bib38","article-title":"Selection of potent neutralizing human monoclonal antibodies to protective antigen of Bacillus anthracis","author":"Choi","year":"2003"},{"key":"10.1016\/j.ymthe.2004.10.018_bib39","first-page":"110","article-title":"Therapeutic monoclonal antibodies: trends in development and approval in the US","volume":"4","author":"Reichert","year":"2002","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.10.018_bib40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.cgt.7700376","article-title":"Recombinant vaccinia viruses expressing immunoglobulin variable regions efficiently and selectively protect mice against tumoral B-cell growth","volume":"8","author":"BenAmmar-Ceccoli","year":"2001","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ymthe.2004.10.018_bib41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0042-6822(02)00094-6","article-title":"Human recombinant neutralizing antibodies against Hantaan virus G2 protein","volume":"308","author":"Koch","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2004.10.018_bib42","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.1128\/JVI.76.17.8769-8775.2002","article-title":"Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer","volume":"76","author":"Lewis","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.10.018_bib43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/viro.1997.8695","article-title":"Baculovirus expression of a human G2-specific, neutralizing IgG monoclonal antibody to Puumala virus","volume":"235","author":"Liang","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2004.10.018_bib44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0022-1759(01)00353-2","article-title":"High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector","volume":"252","author":"Morimoto","year":"2001","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ymthe.2004.10.018_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/375247","article-title":"Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies","volume":"188","author":"Prosniak","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2004.10.018_bib46","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/sj.gt.3302085","article-title":"Single-chain antibody and its derivatives directed against vascular endothelial growth factor: application for antiangiogenic gene therapy","volume":"10","author":"Afanasieva","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2004.10.018_bib47","first-page":"3081","article-title":"A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial","volume":"6","author":"Alvarez","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2004.10.018_bib48","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.gt.3301639","article-title":"Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv","volume":"9","author":"Arafat","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2004.10.018_bib49","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.4049\/jimmunol.168.8.3983","article-title":"Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope","volume":"168","author":"Armstrong","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2004.10.018_bib50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1385\/MB:22:2:191","article-title":"Genetically engineered intracellular single-chain antibodies in gene therapy","volume":"22","author":"Bilbao","year":"2002","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.ymthe.2004.10.018_bib51","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood.V90.9.3699","article-title":"Idiotype vaccines for non-Hodgkin\u2019s lymphoma induce polyclonal immune responses that cover mutated tumor idiotypes: comparison of different vaccine formulations","volume":"90","author":"Caspar","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.10.018_bib52","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1089\/10430340260185111","article-title":"High in vivo production of a model monoclonal antibody on adenoviral gene transfer","volume":"13","author":"Noel","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.10.018_bib53","first-page":"5239","article-title":"Radiosensitization of human tumor cell lines induced by the adenovirus-mediated expression of an anti-Ras single-chain antibody fragment","volume":"59","author":"Russell","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2004.10.018_bib54","first-page":"2318","article-title":"Inhibition of radiation-induced nuclear factor-kappaB activation by an anti-Ras single-chain antibody fragment: lack of involvement in radiosensitization","volume":"62","author":"Russell","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2004.10.018_bib55","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0168-8278(02)00270-2","article-title":"Construction and characterization of an intracellular single-chain human antibody to hepatitis C virus non-structural 3 protein","volume":"37","author":"Sullivan","year":"2002","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymthe.2004.10.018_bib56","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood.V97.5.1370","article-title":"Idiotype-encoding recombinant adenoviruses provide protective immunity against murine B-cell lymphomas","volume":"97","author":"Timmerman","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.10.018_bib57","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/sj.gt.3300685","article-title":"Recombinant adenoviral delivery for in vivo expression of scFv antibody fusion proteins","volume":"5","author":"Whittington","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2004.10.018_bib58","series-title":"Gene Therapy: Therapeutic Mechanisms and Strategies","first-page":"17","article-title":"Adenovirus vectors for gene therapy","author":"Hackett","year":"2000"},{"key":"10.1016\/j.ymthe.2004.10.018_bib59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/biol.1995.0025","article-title":"Recombinant adenoviruses as vaccines","volume":"23","author":"Randrianarison-Jewtoukoff","year":"1995","journal-title":"Biologicals"},{"issue":"1","key":"10.1016\/j.ymthe.2004.10.018_bib60","article-title":"Adenoviral vector safety and toxicity [special issue]","volume":"13","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.10.018_bib61","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199605023341809","article-title":"Adenoviruses as gene-delivery vehicles","volume":"334","author":"Wilson","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2004.10.018_bib62","doi-asserted-by":"crossref","first-page":"11603","DOI":"10.1128\/JVI.75.23.11603-11613.2001","article-title":"Replication-defective vector based on a chimpanzee adenovirus","volume":"75","author":"Farina","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2004.10.018_bib63","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/hum.1996.7.1-79","article-title":"\u201cSero-switch\u201d adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype","volume":"7","author":"Mastrangeli","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.10.018_bib64","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0042-6822(03)00161-2","article-title":"Development of adenovirus serotype 35 as a gene transfer vector","volume":"311","author":"Seshidhar","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2004.10.018_bib65","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1128\/IAI.70.11.6231-6241.2002","article-title":"Postexposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs","volume":"70","author":"Altboum","year":"2002","journal-title":"Infect. Immun."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604015102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604015102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T09:30:57Z","timestamp":1625131857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001604015102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S1525001604015102"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2004.10.018","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}